Equipped with world-leading technology platforms and professional scientific staff, Creative Biolabs is a world-leading services provider in the field of next-generation sequencing (NGS). Based on our versatile SuPrecision™ platform, we offer one-stop small RNA sequencing services for global customers from small RNA extraction to data analysis. We are committed to delivering accurate, affordable and high-quality sequencing data to support your research.
Facing issue in account approval? email us at info@ipt.pw
Click to Ckeck Our - FREE SEO TOOLS
Our cutting-edge hybridoma development and phage display platforms allow the production of the most comprehensive list of recombinant antibody products and extensive service portfolio at the most competitive price. Our products range from antibody / peptide libraries, Biosimilar cell lines, Chimeric antigen receptor (CAR) products, antibody-drug conjugates (ADCs) to engineered antibodies such as therapeutic antibodies, single-domain antibodies, bispecific antibodies and intrabodies. We also provide professional custom antibody discovery and engineering services, featuring phage display librar
Our cutting-edge hybridoma development and phage display platforms allow the production of the most comprehensive list of recombinant antibody products and extensive service portfolio at the most competitive price. Our products range from antibody / peptide libraries, Biosimilar cell lines, Chimeric antigen receptor (CAR) products, antibody-drug conjugates (ADCs) to engineered antibodies such as therapeutic antibodies, single-domain antibodies, bispecific antibodies and intrabodies. We also provide professional custom antibody discovery and engineering services, featuring phage display librar
Anti-centromere antibody (ACA) is a type of natural autoantibody (NAA) directly reacting with the centromere, which has been demonstrated to be related to several autoimmune diseases. Based on over a decade of experience and first-in-class technologies in NAA research, Creative Biolabs has successfully developed a series of diversified NAA platforms and several effective strategies to provide the best and perfect services for our worldwide customers. At present, we are able to provide a full range of anti-centromere antibody (ACA) marker services for diseases diagnosis and therapeutic monitor
During developments of mRNA therapeutics, the stability and translation efficiency remains two pivotal issues at early stage and may have influences throughout the overall development processes even the large scale manufacture and they need to be addressed as early as possible. To this end, Creative Biolabs has developed a comprehensive platform enabling optimization of mRNA synthesis, modification, and delivery method.
During developments of mRNA therapeutics, the stability and translation efficiency remains two pivotal issues at early stage and may have influences throughout the overall development processes even the large scale manufacture and they need to be addressed as early as possible. To this end, Creative Biolabs has developed a comprehensive platform enabling optimization of mRNA synthesis, modification, and delivery method.
Creative Biolabs was established as a biotechnology company specializing in developing and production of antibodies and also a service provider for customized products and relevant services. The company was founded by a group of scientists and entrepreneurs who are committed to changing the traditional antibody model and establishing a new service platform. Employees at Creative Biolabs are composed of elites (Masters & PhD) from top universities worldwide. As an antibody customization service provider, we are dedicated to the research and development of antibodies to animals, plants and micr
Creative Biolabs was established as a biotechnology company specializing in developing and production of antibodies and also a service provider for customized products and relevant services. The company was founded by a group of scientists and entrepreneurs who are committed to changing the traditional antibody model and establishing a new service platform. Employees at Creative Biolabs are composed of elites (Masters & PhD) from top universities worldwide. As an antibody customization service provider, we are dedicated to the research and development of antibodies to animals, plants and micr
Microfluidics offers technology to enable the miniaturization of biological assays, significantly improving the analysis efficiency of samples. The micro-channels are generally small in cross-sectional area and can run many samples in parallel. This parallelization, in conjunction with the small volumes required for a given test, facilitates high-throughput analysis. Creative Biolabs is dedicated to establishing the most exquisite microfluidic platform for our clients and the one-stop microfluidic solutions can provide comprehensive technical support for advancing our clients’ projects.
In recent years, low-cost nucleic acid solutions on microfluidic chips have been developed, which would become a more valuable platform and one of the most common tools in the biomedical field. Creative Biolabs is a leader in microfluidic chip development. With years of experience and advanced microfluidic platforms, our scientists are pleased to offer the best-qualified outcomes to meet our customers' specific requirements for the development of microfluidic chips.
MIYAIRI 588
Since the inception of Creative Biolabs, our research and service capacity has expanded to the entire new drug discovery and development pipeline, including early discovery, preclinical testing, process development, cGMP manufacturing, phase 1-III clinical trials.
in vitro diagnostics of autoimmune
Creative Biolabs is committed to helping you win the race in therapeutic antibody and protein drug discovery and development. Our final goal aims to facilitate your product to market faster with quality assurance in compliance with global regulatory requirements!
Creative Biolabs provides a full range of immune checkpoint antibody development services from antibody discovery to preclinical trials in a timely and cost-effective manner. Our featured services include monoclonal antibody development, phage display antibody library construction and screening, antibody humanization, antibody production, bispecific antibody development, and so on. Besides, we also support immune checkpoint small molecule drug development and immune checkpoint assays to meet your specific requirement. Moreover, we also provide a series of high-quality immune checkpoint-relate
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow treating a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery. There are numerous ongoing researches of which the focus is testing several approaches to gene therapy.
Therapeutic glycoproteins have become the fastest growing fields in the pharmaceutical industry. Creative Biolabs is a leading customer service provider in the field of therapeutic glycoprotein development. Equipped with the latest world-leading technology platforms and professional scientific staff, Creative Biolabs is dedicated to providing high-quality glycoprotein production and corresponding analysis service. Our seasoned scientists are more than happy to share our cutting-edge experience in therapeutic glycoprotein development to meet every unique requirement of our clients.
Creative Biolabs concentrates on promoting the understanding of gamma delta (γδ) T cell receptors breakthroughs in disease therapy. We will combine γδ T cell receptor (TCR) repertoires analysis research with other incredible projects around the world to boost novel γδ T cell development in unprecedented ways. In our company, our scientists specialized in γδ T cell studies will work with you to develop the most appropriate strategy that will offer the reproducible data for your research.
Creative Biolabs is a world-leading service provider that focuses on the research of γδ T cells. With highly skilled and committed experts and state-of-the-art technologies, we are fully confident in offering the best γδ T cell isolation services to support the research of γδ T cell biology and the development of γδ T cell-based immunotherapies.
Exosomes have shown to serve as an effective tool for drugs delivery in the treatment of cardiac diseases. Moreover, they also have shown to enhance cardiac regeneration after myocardial infarction (MI). With the extensive experience in the field of exosome research, Creative Biolabs is confident to provide a full range of exosome-related services for global customers.